Article ID Journal Published Year Pages File Type
4026083 Ophthalmology 2014 7 Pages PDF
Abstract
In this study, tocilizumab was effective in the treatment of refractory inflammatory ME. No serious adverse events were observed.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , , , , ,